These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 8995134)

  • 1. Applications of molecular epidemiology to head and neck cancer.
    Hart TC
    Otolaryngol Clin North Am; 1997 Feb; 30(1):21-34. PubMed ID: 8995134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic alterations in head and neck cancer.
    Somers KD; Schechter GL
    Otolaryngol Clin North Am; 1992 Oct; 25(5):1065-71. PubMed ID: 1408191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of genomic instability in the pathogenesis of squamous cell carcinoma of the head and neck.
    Wiseman SM; Stoler DL; Anderson GR
    Surg Oncol Clin N Am; 2004 Jan; 13(1):1-11. PubMed ID: 15062358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus.
    Smeets SJ; Braakhuis BJ; Abbas S; Snijders PJ; Ylstra B; van de Wiel MA; Meijer GA; Leemans CR; Brakenhoff RH
    Oncogene; 2006 Apr; 25(17):2558-64. PubMed ID: 16314836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of genes involved in squamous cell carcinoma of the lung using synchronized data from DNA copy number and transcript expression profiling analysis.
    Lo KC; Stein LC; Panzarella JA; Cowell JK; Hawthorn L
    Lung Cancer; 2008 Mar; 59(3):315-31. PubMed ID: 18029052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis.
    Andrews GA; Xi S; Pomerantz RG; Lin CJ; Gooding WE; Wentzel AL; Wu L; Sidransky D; Grandis JR
    Head Neck; 2004 Oct; 26(10):870-7. PubMed ID: 15390206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of TESTIN and its association with cancer history and a tendency toward poor survival in head and neck squamous cell carcinoma.
    Gunduz E; Gunduz M; Beder L; Nagatsuka H; Fukushima K; Sutcu R; Delibas N; Yamanaka N; Shimizu K; Nagai N
    Arch Otolaryngol Head Neck Surg; 2009 Mar; 135(3):254-60. PubMed ID: 19289703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations and altered expression of the human cancer genes: what they tell us about causes.
    Devereux TR; Risinger JI; Barrett JC
    IARC Sci Publ; 1999; (146):19-42. PubMed ID: 10353382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variability of genetic alterations in different sites of head and neck cancer.
    Rodrigo JP; Suárez C; González MV; Lazo PS; Ramos S; Coto E; Alvarez I; García LA; Martínez JA
    Laryngoscope; 2001 Jul; 111(7):1297-301. PubMed ID: 11568558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of p53 expression correlates with metastatic phenotype and transcriptional profile in a new mouse model of head and neck cancer.
    Ku TK; Nguyen DC; Karaman M; Gill P; Hacia JG; Crowe DL
    Mol Cancer Res; 2007 Apr; 5(4):351-62. PubMed ID: 17426250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains.
    Redon R; Muller D; Caulee K; Wanherdrick K; Abecassis J; du Manoir S
    Cancer Res; 2001 May; 61(10):4122-9. PubMed ID: 11358835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic instabilities of chromosome 9, 17 and accumulation of p53 overexpression during multistage tumorigesis in head and neck cancer.
    Charuruks N; Shin DM; Voravud N; Ro JY; Hong WK; Hittelman WN
    J Med Assoc Thai; 1996 Dec; 79 Suppl 1():S104-12. PubMed ID: 9071074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications.
    Tabor MP; Brakenhoff RH; van Houten VM; Kummer JA; Snel MH; Snijders PJ; Snow GB; Leemans CR; Braakhuis BJ
    Clin Cancer Res; 2001 Jun; 7(6):1523-32. PubMed ID: 11410486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel integrative methods for gene discovery associated with head and neck squamous cell carcinoma development.
    Smith IM; Mithani SK; Liu C; Chang SS; Begum S; Dhara M; Westra W; Sidranksy D; Califano JA
    Arch Otolaryngol Head Neck Surg; 2009 May; 135(5):487-95. PubMed ID: 19451471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delineating genetic pathways of disease progression in head and neck squamous cell carcinoma.
    Worsham MJ; Pals G; Schouten JP; Van Spaendonk RM; Concus A; Carey TE; Benninger MS
    Arch Otolaryngol Head Neck Surg; 2003 Jul; 129(7):702-8. PubMed ID: 12874067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of gene promoter methylation in squamous cell cancer of the head and neck.
    Hasegawa M; Nelson HH; Peters E; Ringstrom E; Posner M; Kelsey KT
    Oncogene; 2002 Jun; 21(27):4231-6. PubMed ID: 12082610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent deletion and down-regulation of ING4, a candidate tumor suppressor gene at 12p13, in head and neck squamous cell carcinomas.
    Gunduz M; Nagatsuka H; Demircan K; Gunduz E; Cengiz B; Ouchida M; Tsujigiwa H; Yamachika E; Fukushima K; Beder L; Hirohata S; Ninomiya Y; Nishizaki K; Shimizu K; Nagai N
    Gene; 2005 Aug; 356():109-17. PubMed ID: 15935570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Oncogenic activity of head and neck tumors].
    Basterra J; Armengot M; Martorell M; Barona R; Montalt J
    An Otorrinolaringol Ibero Am; 1995; 22(2):197-206. PubMed ID: 7778721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of tumor suppressor genes in bladder cancer.
    Cordon-Cardo C; Reuter VE
    Semin Diagn Pathol; 1997 May; 14(2):123-32. PubMed ID: 9179973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of genetic factors in predisposition to squamous cell cancer of the head and neck.
    Jefferies S; Eeles R; Goldgar D; A'Hern R; Henk JM; Gore M
    Br J Cancer; 1999 Feb; 79(5-6):865-7. PubMed ID: 10070882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.